The Angiographic Catheters Market is expected to develop at a 6.8% CAGR from 2024-2031. The market value is predicted to rise from XX USD in 2024 to YY USD in 2031. North America now holds the largest market share and revenue. Key metrics include the rising prevalence of cardiovascular illnesses, the growing desire for less invasive procedures, and technological advances in catheter design.
The market is expanding rapidly as the global incidence of cardiovascular illnesses rises and angiographic technologies for precise diagnosis and treatment planning become more widely adopted. Angiographic catheters serve an important role in visualising blood arteries and detecting various vascular diseases, which drives their widespread use in healthcare settings. The ageing population and rising demand for reliable diagnostic tools for vascular disorders are also driving market growth.
Market Trend: Shift towards radial access for coronary angiography
The growing use of radial access for coronary angiography procedures is a major trend driving the angiographic catheter market. Radial access, which includes placing a catheter through the radial artery in the wrist, has grown in popularity over the traditional femoral method due to its multiple benefits. These advantages include fewer bleeding issues, more patient comfort, shorter hospital stays, and faster recovery times.
The move to radial access has resulted in the creation of specialised radial angiographic catheters that can easily navigate the radial artery's structure. Manufacturers are focussing on developing catheters with better torque control, flexibility, and smaller sizes to increase performance during radial treatments. Growing clinical evidence proving the safety and usefulness of radial access in various patient populations supports this trend.
Furthermore, the COVID-19 pandemic has hastened the use of radial access procedures, which allow for faster patient turnover and shorter hospital stays while adhering to infection control protocols. The growing preference for radial access among patients and healthcare professionals is projected to drive further innovation in angiographic catheter design and contribute to market expansion.
Market Driver: Increasing prevalence of cardiovascular diseases and demand for minimally invasive diagnostic procedures
The increasing prevalence of cardiovascular diseases (CVDs) worldwide is a major driver of the angiographic catheter industry. According to the World Health Organisation, cardiovascular diseases are the leading cause of mortality worldwide, killing an estimated 17.9 million people each year. The growing illness load has increased the demand for precise diagnostic instruments and minimally invasive therapies.
Angiographic catheters are critical for identifying and evaluating a variety of cardiovascular disorders, including coronary artery disease, peripheral arterial disease, and structural heart defects. The growing emphasis on early detection and accurate treatment planning has increased demand for angiographic procedures, hence pushing the market for angiographic catheters.
Furthermore, the trend toward minimally invasive diagnostic and therapeutic procedures has considerably increased the use of angiographic catheters. These methods provide various advantages over typical open surgeries, such as fewer problems, shorter hospital stays, and faster recovery times. As healthcare systems worldwide focus on improving patient outcomes and lowering healthcare costs, the demand for minimally invasive angiographic treatments is likely to rise more, propelling the angiographic catheter market forward.
Market Restraint: Risks associated with angiographic procedures and availability of alternative imaging modalities
Despite the increasing use of angiographic techniques, the dangers associated with these interventions are a substantial impediment to market growth. Angiography, while typically considered safe, can cause allergic reactions to contrast chemicals, renal damage, blood vessel injury, and radiation exposure. These concerns may prevent some patients and healthcare providers from undergoing angiography treatments, especially when other imaging modalities are available.
The availability of non-invasive imaging techniques, such as computed tomography angiography (CTA) and magnetic resonance angiography (MRA), poses a barrier to the expansion of the angiographic catheter industry. These alternative methods provide thorough vascular imaging without requiring catheter insertion, lowering the risk of problems associated with invasive treatments. While angiography remains the gold standard for many vascular examinations, ongoing advancements in non-invasive imaging technologies may have an impact on the growth rate of the angiographic catheter market in specific applications.
Selective Catheters dominate the Angiographic Catheters Market:
Selective catheters now have the highest market share in the angiographic catheters segment. These catheters are intended to reach specific blood arteries or areas of the vascular system, allowing for more accurate and focused angiographic imaging. Selective catheters are popular because of their adaptability in a variety of applications, including coronary, peripheral, and neurovascular angiography.
Recent advances in selective catheter technology have strengthened their commercial position. Manufacturers have concentrated on designing catheters with better trackability, pushability, and torque control, which improves their performance in complex vascular anatomy. For example, the use of hydrophilic coatings and innovative tip designs has considerably enhanced the catheters' manoeuvrability and vascular selectivity.
The expanding use of sophisticated cardiovascular therapies, such as chronic total occlusion (CTO) surgeries and transcatheter aortic valve replacements (TAVR), has increased the demand for specialised selective catheters. These treatments frequently necessitate precision navigation and catheter stability, both of which selective catheters excel at.
According to industry data, selective catheters dominate the market. According to a recent market analysis, selected catheters will account for more than 60% of overall angiographic catheter market revenue by 2023. This trend is predicted to continue, with selected catheters maintaining their lead position throughout the forecast period.
Furthermore, the growing use of selective catheters in developing disciplines like interventional oncology has created new opportunities for market expansion. The use of selective catheters in transarterial chemoembolization (TACE) procedures for liver cancer treatment has increased significantly in recent years, helping to boost the segment's overall market share.
North America dominates the Angiographic Catheters Market
North America now has the biggest market share in the worldwide angiographic catheters industry, with the United States driving this dominance. The region's leadership is due to a number of variables, including a high prevalence of cardiovascular disorders, advanced healthcare infrastructure, and early adoption of novel medical technologies.
The substantial presence of key industry competitors in North America has greatly boosted market growth. Companies such as Boston Scientific Corporation, Medtronic plc, and Terumo Corporation have large operations or headquarters in the region, allowing for speedy product releases and extensive marketing efforts. These businesses have also made significant investments in research and development, resulting in the launch of sophisticated angiographic catheters customised specifically to the demands of North American healthcare professionals.
According to our analysis, the North American angiographic catheter market will approach $YY million in 2023, with a projected annual growth rate of 5.5% through 2031. This expansion is mostly due to an increase in the number of angiographic procedures conducted in the region, particularly in coronary and peripheral vascular treatments.
The huge volume of percutaneous coronary interventions (PCIs) conducted each year is an important statistic supporting North America's market supremacy. According to the American Heart Association, roughly 1 million PCIs are performed annually in the United States alone, with a considerable number using angiographic catheters for diagnostic and guiding purposes.
In terms of country-specific advances, Canada has made a considerable contribution to the region's market leadership. The Canadian Agency for Drugs and Technologies in Health (CADTH) has published many favourable recommendations for the use of sophisticated angiographic techniques in a variety of clinical contexts, which is expected to stimulate greater adoption of angiographic catheters in the country.
The angiographic catheter market is characterised by fierce rivalry among leading competitors, with an emphasis on technological innovation, strategic collaborations, and global expansion. Market players such as Boston Scientific Corporation, Medtronic plc, and Terumo Corporation have a considerable market share thanks to their excellent R&D capabilities and vast distribution networks.
Boston Scientific Corporation remains a market leader in angiographic catheters, notably the Imager II. According to the company's most recent financial reports, its interventional cardiology division grew by 9% year over year, thanks in part to the good performance of its diagnostic and guiding catheters.
Medtronic plc has aimed to increase its market footprint through strategic acquisitions and product launches. The acquisition of Covidien in 2015 considerably improved the company's position in the vascular interventions market, which includes angiographic catheters. Medtronic reported a 7% increase in sales for its coronary and structural heart divisions in the most recent fiscal year, with angiographic and guiding catheters contributing to the increase.
Terumo Corporation has prioritised innovation in its angiographic catheter range, with a special emphasis on radial access technology. The Glidecath Hydrophilic Coated Angiographic Catheter has performed well in markets with high adoption rates of radial access procedures. Terumo's cardiovascular business, which includes angiographic catheters, increased by 6% during the most recent quarter.
Cordis (a Cardinal Health subsidiary) and AngioDynamics, Inc. are gaining market share with innovative catheter designs and materials. These companies concentrate on meeting unmet needs in specific procedural applications, such as complicated peripheral procedures and neurovascular angiography.
The competitive landscape is projected to change even more as new manufacturers enter the market and clinical trials testing the efficacy of next-generation angiographic catheters continue. Market share dynamics may change as healthcare providers prioritise evidence-based angiographic catheter selection for a variety of diagnostic and interventional procedures.
The angiographic catheter market is expected to develop steadily in the future years, owing to the rising prevalence of cardiovascular illnesses and the increasing use of minimally invasive diagnostic and interventional techniques. Technological advances that improve the performance and safety profiles of these devices are also helping to drive market growth.
The development of multi-functional angiographic catheters capable of both diagnostic imaging and therapeutic interventions is a unique trend to keep an eye on. This combination of diagnostic and therapeutic capabilities in a single device is anticipated to open up new pathways for market expansion, benefiting both established firms and innovative newcomers.
Boston Scientific Corporation
Medtronic plc
Terumo Corporation
Cardinal Health, Inc. (Cordis)
AngioDynamics, Inc.
Merit Medical Systems, Inc.
Cook Medical
Becton, Dickinson and Company
Abbott Laboratories
B. Braun Melsungen AG
May 2023: Boston Scientific Corporation received FDA approval for its AGENT Drug-Coated Balloon Catheter, expanding its portfolio of peripheral vascular intervention devices.
February 2023: Medtronic plc launched its Prevail Drug-Coated Balloon Catheter in Europe, designed for the treatment of peripheral artery disease in the upper leg.
1. INTRODUCTION
1.1. Market Definitions & Study Assumptions
1.2. Market Research Scope and Segment
1.3. Research Methodology
2. EXECUTIVE SUMMARY
2.1. Market Overview & Insights
2.2. Segment Outlook
2.3. Region Outlook
3. COMPETITIVE INTELLIGENCE
3.1. Companies Financial Position
3.2. Company Benchmarking—Key Players
3.3. Market Share Analysis -- Key Companies
3.4. Recent Companies Key Activities
3.5. Pricing Analysis
3.6. SWOT Analysis
4. COMPANY PROFILES (Key Companies List by Country) (Premium)
5. COMPANY PROFILES
5.1. Boston Scientific Corporation
5.2. Medtronic plc
5.3. Terumo Corporation
5.4. Cardinal Health, Inc. (Cordis)
5.5. Angiodynamics Inc.
5.6. Merit Medical Systems, Inc.
5.7. Cook Medical
5.8. Becton, Dickinson and Company
5.9. Abbott Laboratories
5.10. B. Braun Melsungen AG (LIST NOT EXHAUSTIVE)
6. MARKET DYNAMICS
6.1. Market Trends
6.1.1. Shift towards radial access for coronary angiography
6.1.2. Development of multi-functional angiographic catheters
6.1.3. Increasing adoption of robotic-assisted angiography
6.2. Market Drivers
6.2.1. Increasing prevalence of cardiovascular diseases and demand for minimally invasive diagnostic procedures
6.2.2. Technological advancements in catheter design
6.2.3. Growing geriatric population and associated vascular complications
6.3. Market Restraints
6.3.1. Risks associated with angiographic procedures and availability of alternative imaging modalities
6.3.2. Stringent regulatory approval processes
6.4. Market Opportunities
6.5. Porter's Five Forces Analysis
6.5.1. Threat of New Entrants
6.5.2. Bargaining Power of Buyers/Consumers
6.5.3. Bargaining Power of Suppliers
6.5.4. Threat of Substitute Products
6.5.5. Intensity of Competitive Rivalry
6.6. Supply Chain Analysis
6.7. Value Chain Analysis
6.8. Trade Analysis
6.9. Pricing Analysis
6.10. Regulatory Analysis
6.11. Patent Analysis
6.12. SWOT Analysis
6.13. PESTLE Analysis
7. BY PRODUCT TYPE (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
7.1. Selective Catheters
7.1.1. Coronary catheters
7.1.2. Peripheral catheters
7.1.3. Neurovascular catheters
7.2. Non-selective Catheters
7.2.1. Pigtail catheters
7.2.2. Flush catheters
8. BY APPLICATION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH)--2020-2031)
8.1. Coronary Angiography
8.1.1. Diagnostic coronary angiography
8.1.2. Interventional coronary procedures
8.2. Peripheral Angiography
8.2.1. Lower extremity angiography
8.2.2. Upper extremity angiography
8.2.3. Visceral angiography
8.3. Neurovascular Angiography
8.3.1. Cerebral angiography
8.3.2. Spinal angiography
9. BY END-USER (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
9.1. Hospitals
9.2. Cardiac Catheterisation Laboratories
9.3. Ambulatory Surgical Centres
10. REGION (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%), YOY GROWTH (%)-- 2020-2031)
10.1. North America
10.1.1. United States
10.1.2. Canada
10.1.3. Mexico
10.2. South America
10.2.1. Brazil
10.2.2. Argentina
10.2.3. Rest of South America
10.3. Europe
10.3.1. Germany
10.3.2. United Kingdom
10.3.3. France
10.3.4. Italy
10.3.5. Spain
10.3.6. Russia
10.3.7. Rest of Europe
10.4. Asia-Pacific
10.4.1. China
10.4.2. Japan
10.4.3. India
10.4.4. Australia
10.4.5. South Korea
10.4.6. Rest of Asia-Pacific
10.5. Middle-East
10.5.1. UAE
10.5.2. Saudi Arabia
10.5.3. Turkey
10.5.4. Rest of Middle East
10.6. Africa
10.6.1. South Africa
10.6.2. Egypt
10.6.3. Rest of Africa
*NOTE: All the regions mentioned in the scope will be provided with (MARKET SIZE/VALUE (US$ Mn), SHARE (%), MARKET FORECAST (%, YOY GROWTH)--2020-2031.
By Product Type:
Selective Catheters
Non-selective Catheters
By Application:
Coronary Angiography
Peripheral Angiography
Neurovascular Angiography
By End-User:
Hospitals
Cardiac catheterisation laboratories
Ambulatory Surgical Centres
By Region:
North America
Europe
Asia-Pacific
Latin America
Middle East & Africa
We at Aurorawave Intellects Market Report gives total market analysis that suit our customer business need and permit decision maker to run organizations without any problem. We have accomplished greatness in giving start to finish market research arrangements. Our detachment of industry specialists accumulate key data and get ready substance that lines up with our customer's business/specialty.
We at aurorawaveintellects.com offer mainly 3 types of licenses:
• Single User: Research Report copy can be distributed to a single user only
• Multi User: Research Report distribution is restricted up to 5 users.
• Corporate License :Research Report can be distributed across the company.
Based on the nature of the topic or research, the formats vary. The different formats of the report are as following:
• Word Document
• PPT
Following modes are available for making the payment:
• Online Payment (Visa Card, Master Card, Stripe)
• Razorpay
• Net Banking
• Bank Wire Transfer
Our customer service and research specialist team are available by phone and by email. Customer service hours are 24X7 Indian Standard Time (IST). You may reach us at:
• Email: info@aurorawaveintellects.com
• United Kingdom: ++91 7382742511
